Grafton Optical launches new I-Drop product
The eye drops are designed to manage and relieve symptoms associated with lid margin diseases
The eye drops are designed to manage and relieve symptoms associated with lid margin diseases such as dry eye, Meibomian gland dysfunction and blepharitis.
Grafton Optical explained that I-Drop combines biopolymers, viscoelastic hyaluronan and low molecular weight glycerine lubricant, for long-lasting comfort and relief.
CEO of Grafton Optical, David Thickens, said: “The I-Drop range is exclusive to Grafton Optical in the UK and will not be available to buy in pharmacies or online. This provides a protected sales channel for optometrists and ophthalmologists recommending these products to their patients.”
For further information, visit the Grafton Optical website.